Hepatocellular carcinoma (HCC) presents a unique challenge for radiation oncology: treating a moving target within a functionally vulnerable organ.

As liver SBRT gains momentum across the HCC care continuum, advanced imaging is helping clinicians understand where tumors are, how they move, and how to treat them with confidence while preserving healthy liver function. At the same time, growing clinical evidence continues to expand the role of radiotherapy in multidisciplinary liver cancer management.

Drawing on both emerging clinical evidence and experience from the University of California, San Francisco liver cancer radiotherapy program, this webinar will explore how advanced MR imaging is helping clinicians stay one step ahead of a moving target. Join UCSFs Professor of Medical Physics Wensha Yang and Allegheny Health Network's Academic Chief Sushil Beriwal and discover how MR-supported SBRT can improve target definition, uncover motion patterns that may be missed with conventional imaging, and support treatment strategies designed to balance durable tumor control with preservation of hepatic function.

After viewing the webinar participants should be able to: 

- Describe the evolving role of SBRT in hepatocellular carcinoma management, including emerging evidence supporting its use across multiple clinical scenarios and disease stages

- Recognize key considerations in implementing advanced imaging within a liver cancer radiotherapy program, including multidisciplinary collaboration, motion management, and patient selection.

- Evaluate the emerging role of MRI-based motion assessment for individualized liver radiotherapy planning and liver preservation strategies